Granulocyte Donation in India: The Rarest Blood Component and Who Needs It

Most blood donors have heard of donating red blood cells, platelets, and plasma. Few have heard of donating granulocytes — white blood cells that are the immune system's frontline defence against bacterial and fungal infections.

Granulocyte donation is the rarest and most logistically demanding blood component procedure in medicine. The cells must be transfused within 24 hours of collection — there is no storage, no stock to draw from, no advance preparation. When a patient needs granulocytes, a donor must be found, screened, stimulated, collected from, and the cells must reach the patient — all within a single day.

In India, only a handful of blood banks at major tertiary cancer and transplant centres offer this service. And the patients who need it — typically severely immunocompromised transplant recipients or neutropenic patients with life-threatening infections — have often exhausted every other treatment option.

Understanding granulocyte donation is not essential for most blood donors. But for those willing to be contacted for this rare, urgent procedure, it represents one of the most directly impactful acts available in blood banking.

What Are Granulocytes?

Granulocytes are a category of white blood cells named for the granules visible in their cytoplasm under microscopy. They include neutrophils (the most abundant and most important for this context), eosinophils, and basophils.

Neutrophils are the body's primary defence against bacterial and fungal infections. When bacteria enter a wound, surgical site, or the bloodstream, neutrophils are the first responders — engulfing and destroying pathogens before they can proliferate.

A healthy adult has approximately 1.8–7.7 billion neutrophils per litre of blood. When this count falls below 0.5 billion per litre — a condition called severe neutropenia — the immune system is essentially defenceless against infection.

Who Needs Granulocyte Transfusion?

Granulocyte transfusion is a last-resort treatment for patients with:

Bone marrow transplant recipients: During the engraftment period after transplant, the patient's bone marrow is non-functional — producing no blood cells, including no neutrophils. Patients are profoundly neutropenic for 2–4 weeks. If a severe bacterial or fungal infection breaks through during this window — despite prophylactic antibiotics and antifungals — granulocyte transfusion may provide a temporary immune defence bridge until the transplanted marrow engrafts.

Leukaemia patients on intensive chemotherapy: Induction chemotherapy for acute leukaemia destroys bone marrow function, creating prolonged neutropenia during which life-threatening infections can develop. For infections unresponsive to antibiotics and antifungals, granulocyte transfusion is occasionally lifesaving.

Congenital neutrophil disorders: Rare inherited conditions like chronic granulomatous disease (CGD) — where neutrophils are present but non-functional — may benefit from granulocyte transfusion during severe infections.

Aplastic anaemia: Patients with aplastic anaemia (bone marrow failure) face the same neutropenia risk as post-transplant patients.

In all these scenarios, the patient is typically described as "critically ill, not responding to antibiotics, with life-threatening infection and no functional neutrophils." The decision to request granulocyte transfusion is made by experienced haematologists when other options have failed.

The Granulocyte Collection Process: What Donors Experience

Granulocyte donation involves a one-day process significantly more demanding than whole blood or platelet donation:

Step 1: G-CSF and Corticosteroid Stimulation (Day Before Collection)

Granulocytes circulate in relatively low numbers in peripheral blood — too few to collect therapeutically in a single apheresis session under normal conditions. To increase the count sufficiently, the donor receives:

• G-CSF (Granulocyte Colony-Stimulating Factor) injection — a growth factor that stimulates bone marrow to rapidly produce and release large numbers of neutrophils
• Corticosteroid (typically dexamethasone) injection — further mobilises marginated neutrophils

These injections are given 12–24 hours before collection. Side effects include bone pain (most common — the bone marrow working overtime to produce cells), headache, myalgia (muscle aches), and flu-like symptoms. These side effects are temporary — resolving within 24–48 hours after the injections — but they are more significant than anything experienced in whole blood or platelet donation.

The donor must be medically assessed before receiving these medications to ensure they are appropriate candidates.

Step 2: Apheresis Collection (Collection Day)

On collection day, the donor undergoes apheresis — typically taking 4–5 hours (longer than platelet apheresis). Blood is processed through an apheresis machine that selects and retains granulocytes, returning red blood cells, platelets, and plasma to the donor.

The citrate anticoagulant used causes transient tingling; calcium supplements are routinely given.

Step 3: Product Irradiation and Immediate Use

The collected granulocyte concentrate must be:

• Irradiated to prevent TA-GvHD (since granulocyte products contain T-lymphocytes)
• Tested for ABO compatibility
• Transfused within 24 hours of collection

The urgency is absolute. A granulocyte product cannot be stored for tomorrow's round.

Where Granulocyte Transfusion Is Available in India

Given the demanding logistics, granulocyte transfusion is offered at only the most sophisticated blood banking centres in India:

Kerala:

• Malabar Cancer Centre, Thalassery — Offers granulocyte collection; has NAT testing, irradiation capability, and supports a bone marrow transplant programme performing approximately 20 transplants annually

Tamil Nadu:

• Cancer Institute (Adyar Cancer Institute), Chennai — Offers granulocyte collection alongside full apheresis suite including platelet, stem cell, therapeutic plasma exchange, and therapeutic leucoreduction

Maharashtra:

• Tata Memorial Hospital, Mumbai — India's most renowned cancer centre; performs bone marrow transplants extensively and supports granulocyte collection for transplant and intensive chemotherapy patients

West Bengal:

• Tata Medical Centre, Kolkata — Has detailed donor FAQ and appointment system for SDP and granulocyte procedures

Delhi:

• AIIMS New Delhi Blood Bank — National referral centre with granulocyte capability
• Rajiv Gandhi Cancer Institute Blood Bank

Andhra Pradesh:

• NTR Trust Blood Centres, Hyderabad — Expanding apheresis services

How to Become a Granulocyte Donor

Granulocyte donation is not something donors typically volunteer for spontaneously — the logistics require advance arrangement. The process:

1. Register at an apheresis blood bank as a potential granulocyte donor — blood banks like Malabar Cancer Centre, Adyar Cancer Institute, or Tata Memorial maintain lists of willing granulocyte donors
2. Undergo baseline health assessment — blood pressure, general health, absence of conditions that would contraindicate G-CSF and corticosteroids
3. Consent to urgent contact — when a patient in the centre needs granulocytes urgently, the blood bank calls their registered donor list
4. Be available on short notice — granulocyte collection is typically arranged within 24–48 hours of clinical need; donors must be reachable and able to come in quickly
5. Be prepared for the stimulation side effects — the bone pain from G-CSF, while temporary, can be moderately uncomfortable

Who should consider granulocyte donation:

• Regular voluntary blood or platelet donors who have established relationships with major cancer centre blood banks
• People who understand the demanding logistics and are genuinely willing to respond urgently
• People who live near a centre with granulocyte capability — same-day travel is typically required

The Medical Ethics of Donor Stimulation

Granulocyte collection involves administering growth factors and corticosteroids to healthy donors — medicines that alter the donor's body chemistry for the recipient's benefit. This is ethically more complex than conventional blood donation.

Medical ethics committees and blood banks that offer granulocyte services have developed protocols to ensure donors are fully informed, giving truly voluntary consent, and monitored for adverse effects. Risks from G-CSF and corticosteroids in healthy donors are generally mild and transient — but they are real, and donors deserve complete information.

The decision to donate granulocytes is not one to make casually. It is one to make with full information, genuine willingness, and understanding of what the patient on the other side needs from you.

Register on TheBloodApp and indicate your blood type. If you are interested in granulocyte donation specifically, contact the blood bank at your nearest cancer or transplant centre directly — Malabar Cancer Centre, Adyar Cancer Institute, Tata Memorial, AIIMS Delhi — and ask about their granulocyte donor registry. To find blood banks and donation opportunities near you, call the number listed in the app.

Sources: PMC — Malabar Cancer Centre Platelet Apheresis Kerala | Adyar Cancer Institute Blood Bank — Apheresis Procedures | Tata Medical Centre Kolkata — Donor FAQ | eRaktKosh MoHFW — Blood Components | NBTC India — Granulocyte Transfusion | WHO Blood Products Technical Manual